Summit discusses latest regulations and best practices in GCC pharmaceuticals sector

Summit discusses latest regulations and best practices in GCC pharmaceuticals sector

Dubai, United Arab Emirates, (AETOSWire) Government authorities in the Gulf region and leading healthcare solutions providers came together at the sixth GCC Regulatory Affairs Pharma Summit this week to discuss regulations and best practices relating to drug registration and approvals in the region. The two-day virtual summit supported by the UAE Ministry of Health and Prevention was aimed to showcase new developments in the pharmaceuticals sector in GCC as well as their impact on improving patient access to medicines. Over 300 professionals from public health authorities and the pharmaceutical supply…

Abu Dhabi’s Technology Innovation Institute to Build UAE’s First Quantum Computer

Abu Dhabi’s Technology Innovation Institute to Build UAE’s First Quantum Computer

The Institute will construct the computer at its Quantum Research Centre labs, in collaboration with Barcelona-based Qilimanjaro Quantum Tech Abu Dhabi, United Arab Emirates, 23 March 2021, (AETOSWire) – Work is underway to build a quantum computer in Abu Dhabi, in the United Arab Emirates, ushering an important milestone for the region in this breakthrough era in computing. Technology Innovation Institute (TII), the dedicated ‘applied research’ pillar of Abu Dhabi’s newly established Advanced Technology Research Council (ATRC), today announced that its Quantum Research Centre (QRC) team led by its Chief…

ARRAY OF INITIATIVES FROM THUMBAY GROUP PLAYS A VITAL ROLE 

  IN COMBATING COVID-19 IN UAE The Group has dedicated Thumbay Hospital Dubai and Thumbay Hospital Ajman housing 250 beds for the treatment of Covid-19 patients Two clinics converted into Covid-19 Testing Centers, daily conducting 3500 Covid-19 tests February 14th, 2021; Dubai, UAE: In support of UAE government’s fight against Covid-19, the Thumbay Group has conducted several educational and healthcare awareness programs during the last 10 months benefiting more than 100,000 professionals and general public. The strategy combines technology utilization, safety precautions, and awareness programs, training and confidence-building, in addition…

Doctors at Abu Dhabi hospital perform the first hologram surgery  in the UAE  

“مدينة برجيل الطبية” تستخدم تقنية ثلاثية الأبعاد في إجراء عملية

The groundbreaking surgery was performed by the doctors at Burjeel Medical City in partnership with technology-giant Microsoft Doctors at an Abu Dhabi hospital has made history by successfully performing a 3D hologram surgery. The medical procedure employing the groundbreaking technology was conducted at the hospital in partnership with technology giant Microsoft. In the presence of His Excellency, Sheikh Khalid bin Abdullah Al Khalifa, the Ambassador of the Kingdom of Bahrain to the United Arab Emirates, and Dr. Klaus Boecker, Chief Medical and Operations Officer at Daman, Dr. Shamsheer Vayalil, Chairman…

COVID-19 Vaccination is now available  at Zulekha Hospital Sharjah free of charge

لقاح كوفيد-19 مجاناً بمستشفى زليخة

For the benefit of the Greater Community, this service is being offered at “free of cost” to everyone holding a valid Emirates ID. As you are aware the SARS-CoV-2 vaccine from Sinopharm is inactivated registered vaccine in the UAE which provides acquired immunity against COVID-19. Moreover, this vaccine will be given in term of two doses with an interval 21 – 28 days between the first & second doses. Based on initial results of phase 3 trials have shown it has an overall efficacy of 86%. The analysis also shows…

Atomwise and FutuRx Launch A2i Therapeutics – A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority

Atomwise and FutuRx Launch A2i Therapeutics – A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority

SAN FRANCISCO & NESS ZIONA, Israel–(BUSINESS WIRE/AETOSWire) – Atomwise, the leader in using artificial intelligence (AI) for small-molecule drug discovery, announced today a partnership with FutuRx, a recognized Israeli-based biotechnology incubator focused on innovative, early-stage therapeutic technologies. The collaboration will serve as the first introduction of Atomwise’s AtomNet® platform for AI-based drug discovery to a growing biotech innovation hub in Israel and is Atomwise’s second partnership with a global incubator hub. Founded through a joint investment between Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures Inc., OrbiMed Israel Partners, FutuRx has formed over 20…

Recognizes Six Exceptional Female Scientists from the GCC

Recognizes Six Exceptional Female Scientists from the GCC

7th L’Oréal-UNESCO for Women in Science Middle East Regional Young Talents Program Recognizes Six Exceptional Female Scientists from the GCC Grants totalling EUR 84,000 awarded to six researchers for their revolutionary researches in STEM  For the seventh consecutive year, L’Oréal-UNESCO For Women in Science Middle East Regional Young Talents Program, in partnership with Khalifa University of Science and Technology, continues to recognize Arab female scientists from the GCC for their revolutionary researches in the fields of Life sciences, Physical sciences, Mathematics and Computer science. The regional program is part of…

Hikma continues strong 2020 performance and updates full year guidance

Hikma continues strong 2020 performance and updates full year guidance

Amman, Jordan, (AETOSWire) – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Siggi Olafsson, Hikma’s CEO, said: “Hikma is performing well, maintaining the positive momentum of the first half.  The breadth of our portfolio, the flexibility of our manufacturing capabilities and the strength of our commercial and distribution channels are enabling us to supply the medicines most needed by our customers, including those used in the treatment of COVID-19.  We continue to see good demand for our marketed products and are delivering a…

Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies

Aerogen Collaborates on Development of More Than 15 Potential COVID-19 Inhaled Therapies

GALWAY, Ireland–(BUSINESS WIRE/AETOSWire)— Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to support pharmaceutical companies from around the world as they work to develop COVID-19 vaccines and treatments. To date, more than ten million patients globally have been treated safely and effectively with Aerogen’s drug delivery technology 1,5–7. As the global scientific community rallies against the pandemic, there has been unprecedented interest in inhaled delivery of antiviral drugs, leading to Aerogen’s involvement in multiple COVID-19 drug development initiatives with leading pharmaceutical companies…

NOVARTIS sheds light and pioneers in research and activities  to raise awareness on Sickle Cell Disease

نوفارتس تسلّط الضوء على داء فقر الدّم المنجلي

Sickle Cell Disease is one of the most common chronic blood disorders in the world1. Globally around 300,000 babies are born with the disease annually while 300 million people carry the trait.4,9 Gulf is a region with one of the highest prevalence rates of Sickle Cell Disease among Middle Eastern ancestry marking Saudi, Oman, and Bahrain as the countries with the highest rates respectively.17 Sickle cell pain crises or VOCs are considered the clinical hallmark of the disease, and are triggered, in part, by multicellular interactions that form clusters of…